However, C-terminally truncated forms of Asxl1 that are similar to the most abundant ASXL1 mutations occurring in CHIP and myeloid malignancies, produce different effects, namely enlarged hematopoietic stem cell (HSC) pool and increased susceptibility to leukemic transformation [58,59,60]. The gene discussed is ASXL1; the disease is myeloid neoplasm.